ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $58,942,000 | +150.4% | 1,272,213 | +31.8% | 0.15% | +149.2% |
Q1 2019 | $23,537,000 | +214.9% | 965,413 | +84.1% | 0.06% | +195.0% |
Q4 2018 | $7,474,000 | -27.3% | 524,513 | -22.5% | 0.02% | -20.0% |
Q3 2018 | $10,284,000 | -43.2% | 676,600 | -37.3% | 0.02% | -49.0% |
Q2 2018 | $18,118,000 | -15.7% | 1,079,713 | -18.0% | 0.05% | -15.5% |
Q1 2018 | $21,482,000 | +37.7% | 1,316,313 | +8.0% | 0.06% | +38.1% |
Q4 2017 | $15,606,000 | -8.9% | 1,219,240 | -12.4% | 0.04% | -14.3% |
Q3 2017 | $17,123,000 | +727.2% | 1,392,093 | +462.9% | 0.05% | +600.0% |
Q2 2017 | $2,070,000 | -44.2% | 247,300 | -40.4% | 0.01% | -41.7% |
Q1 2017 | $3,712,000 | +195.3% | 415,249 | +190.4% | 0.01% | +140.0% |
Q4 2016 | $1,257,000 | -25.6% | 143,013 | -42.9% | 0.01% | -28.6% |
Q3 2016 | $1,690,000 | +93.1% | 250,413 | +1.9% | 0.01% | +75.0% |
Q2 2016 | $875,000 | -18.8% | 245,713 | -32.8% | 0.00% | -33.3% |
Q1 2016 | $1,078,000 | -31.4% | 365,413 | -1.9% | 0.01% | -33.3% |
Q4 2015 | $1,571,000 | -16.2% | 372,313 | -4.9% | 0.01% | -25.0% |
Q3 2015 | $1,874,000 | -53.1% | 391,513 | -29.4% | 0.01% | -61.3% |
Q2 2015 | $3,999,000 | +179.5% | 554,647 | +185.7% | 0.03% | +181.8% |
Q1 2015 | $1,431,000 | +306.5% | 194,113 | +160.5% | 0.01% | +266.7% |
Q4 2014 | $352,000 | +130.1% | 74,513 | +130.6% | 0.00% | +200.0% |
Q1 2014 | $153,000 | -37.8% | 32,313 | -33.7% | 0.00% | -50.0% |
Q4 2013 | $246,000 | – | 48,713 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MUFG Americas Holdings Corp | 36,200 | $71,000 | 0.00% |